FEATURED COLLABORATION
See how our EDS technology is being leveraged to deploy vaccines as part of DARPA NOW.
Learn More ▶
FEATURED APPLICATION
See how primers produced using our EDS technology were used for sequencing and analysis of SARS-CoV-2.
Learn More ▶
SYNTAX System:
The world’s first DNA printer powered by EDS
Powered by Enzymatic DNA Synthesis (EDS), the SYNTAX System puts you in control of DNA oligo production. Create custom DNA oligos that are ready to use the same day you need them.
DISCOVER THE POWER OF SYNTAX
Accessible
- On-demand, in-house oligo production
- No specialized training or skills required
- Simple and safe
Convenient, Fast, and Flexible
- Update or modify designs in minutes with plug-and-play workflows
- Produce variable DNA oligo lengths and batch sizes
- Micromolar scale supports single use and rapid iteration
Full Control from Sequence to Application
- Improved control over sequence information and security
- Freedom from delays or backorders
- Accelerate innovation and reduce hidden project costs
See how we’re revolutionizing biological research
MEDIA COVERAGE
DNA Script Snags $165M to Build Up Benchtop DNA Synthesis Market, Technology
(Subscription required) DNA Script Aims to Deliver Benchtop DNA Synthesis, Compete With Traditional Synthesis-as-a-Service Providers. South San Francisco and Paris-based … Learn More ▶
MEDIA COVERAGE
French biotech DNA Script raises 142 million euros
This Tuesday, October 26, Thomas Ybert, co-founder and CEO of DNA Script, looked at… … Learn More ▶
The technology
Enzymatic DNA Synthesis (EDS) offers significant advantages in accessibility and convenience, transforming the pace of and control over custom DNA oligo production, with reduced environmental impact over traditional outsourced, chemical-based synthesis.
LEARN MORE ABOUT EDS
Applications in molecular biology, genomics, and more
See how industry leaders are using our SYNTAX Platform to power discoveries in genomics, personalized medicine, and beyond.
VIEW APPLICATIONS
